Stay updated on Nivolumab & Lenvatinib in HCC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab & Lenvatinib in HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab & Lenvatinib in HCC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.2 to v3.6.3 in the footer, signaling a small maintenance release.
    Difference
    0.1%
    Check dated 2026-07-04T09:14:31.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The page revision changed from v3.6.0 to v3.6.2, indicating a newer version of the page was published. This typically reflects minor updates or fixes without altering the study data or key details.
    Difference
    0.1%
    Check dated 2026-06-27T06:22:38.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Recruitment status updated to 'No longer looking for participants', indicating that enrollment has ended. New sections—How to Read a Study Record, Common Questions, and How to Join a Study—were added, the Intervention / Treatment header was standardized to Intervention/Treatment, and a Revision: v3.6.0 note was added.
    Difference
    0.4%
    Check dated 2026-06-13T04:28:08.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision updated from v3.5.4 to v3.5.5. This reflects a minor platform update to the page rendering rather than changes to study data or content.
    Difference
    0.1%
    Check dated 2026-06-05T22:14:10.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Footer now displays the revised site version 'Revision: v3.5.4', replacing 'Revision: v3.5.3'. This marks a minor update to the page template.
    Difference
    0.1%
    Check dated 2026-05-15T14:59:03.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    The page now displays a newer software/site revision identifier (“Revision: v3.5.3”) rather than the previous one (“Revision: v3.5.2”). This reflects a version update of the ClinicalTrials.gov page tooling rather than any change to the underlying study information.
    Difference
    0.1%
    Check dated 2026-04-24T05:53:05.000Z thumbnail image

Stay in the know with updates to Nivolumab & Lenvatinib in HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab & Lenvatinib in HCC Clinical Trial page.